Genetic detection rates lower for Blacks than non-Hispanic Whites based on data collected at the University of Michigan, Blueprint Genetics
Impairments seen for both persistent low and high body mass index
Demographic factors, including sex, age younger than 40 years, age 40 years and older, showed diverse associations with risk for outcomes
Primary composite reactogenicity outcome noninferior for those receiving both vaccines simultaneously
12-year risk for urinary or sexual complications 7.23 and 2.76 times higher for prostatectomy, radiotherapy versus no treatment
Highest percentage with mild, moderate, severe symptoms of anxiety or depression was seen for adults aged 18 to 29 years
Findings independent of other established risk factors
Cancer cases and deaths projected to nearly triple in low-HDI countries by 2050 compared with moderate increase in very high-HDI countries
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden
Age-adjusted CMM incidence rate was 0.99 per 1,000 from 2012 to 2016, marking an increase from previous years
Findings seen for incidence of overall and 14 site-specific cancers
Respiratory syncytial virus vaccination effective for adults aged at least 60 years
35 percent lower risk for diabetes, 20 percent reduced risk for hypertension seen for sugar restriction in first three years after conception